Manufacturer record
Regain Laboratories: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Regain Laboratories (Haryana) were declared Not of Standard Quality between March 2019 and June 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Regain Laboratories in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Frusemide Injection I.P. 2 ml (Rasix Injection) | IFMI415Mfg 2024-09 · Exp 2026-08 | pH? and SterilitySterility | State Lab KarnatakaState lab | Jun 2025 |
| Gentamicin Injection IP (Gentatore Injection 80 mg/2ml) | IGMG418Mfg 2024-07 · Exp 2026-06 | Particulate matter and DescriptionDescription | CDL KolkataCDSCO lab | Apr 2025 |
| AARDEX 4 mg/ml (Dexamethasone Sodium Phosphate Injection IP) | RD-84Mfg 2018-08 · Exp 2020-07 | AssayAssay | CDTL MumbaiCDSCO lab | Mar 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.